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Abstract: Nocturnal bronchoconstriction is a common symptom of asthma in humans, but is 
poorly documented in animal models. Thoracoabdominal asynchrony (TAA) is a noninvasive 
clinical indication of airway obstruction. In this study, respiratory inductive plethysmography 
(RIP) was used to document nocturnal TAA in house dust mite (HDM)-sensitive Cynomolgus 
macaques. Dynamic compliance (Cdyn) and lung resistance (RL) measured in anesthetized   animals 
at rest and following exposure to HDM allergen, methacholine, and albuterol were highly 
  correlated with three RIP parameters associated with TAA, ie, phase angle of the rib cage and 
abdomen waveforms (PhAng), baseline effort phase relation (eBPRL) and effort phase relation 
(ePhRL). Twenty-one allergic subjects were challenged with HDM early in the morning, and 
eBPRL and ePhRL were monitored for 20 hours after provocation. Fifteen of the allergic subjects 
exhibited gradual increases in eBPRL and ePhRL between midnight and 6 am, with peak activ-
ity at 4 am. However, as in humans, this nocturnal response was highly variable both between 
subjects and within subjects over time. The results document that TAA in this nonhuman primate 
model of asthma is highly correlated with Cdyn and RL, and demonstrate that animals exhibiting 
acute responses to allergen exposure during the day also exhibit nocturnal TAA.
Keywords: nocturnal asthma, late phase asthmatic response, respiratory inductive 
plethysmography
Introduction
Allergic asthma is a common disease in developed countries, with an incidence of 
approximately 8% in the US.1 Nocturnal symptoms of asthma are common and include 
bronchoconstriction, airway inflammation and hyperreactivity, dyspnea, cough, and 
apnea.2–6 The incidence and magnitude of nocturnal asthma is variable. Approximately 
70% of asthmatics experience nocturnal symptoms at least once per week, and 10% 
experience nocturnal symptoms at least three times per week.7 Nocturnal symptoms 
can be severe, and a high incidence of respiratory arrest and deaths due to asthma is 
seen between midnight and 8 am.8–10 The mechanisms underlying nocturnal asthma 
have not been elucidated.
Early and late asthmatic responses have been routinely investigated using animal 
models, but nocturnal symptoms are poorly documented in these models due in part 
to the nocturnal nature of rodents and to the techniques commonly used to assess 
  bronchoconstriction in larger diurnal laboratory animals. Respiratory inductive plethys-
mography (RIP) is a noninvasive technique for monitoring breathing patterns11–26 
and may be applicable to nocturnal studies in large animals. RIP uses deflection of 
the ribcage and abdomen to estimate changes in lung volume and airflow, and the Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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phase relationship of abdominal and thoracic movements. 
Restricting airflow through the airways causes movements 
of the thorax and abdomen to be out of phase, giving rise to 
thoracoabdominal asynchrony (TAA). TAA is a common 
clinical indicator of airway obstruction,15,27–31 and in this study 
was used to detect nocturnal respiratory disturbances.
Nonhuman primates (NHP) exhibit a high level of 
similarity to humans in genetic, anatomic, and physiologic 
aspects, and are well suited to modeling human diseases 
(eg, asthma).32 The house dust mite (HDM) model of aller-
gic asthma in Cynomolgus macaques reproduces the key 
features of human asthma, including elevated serum IgE 
levels, β-agonist reversible bronchoconstriction, and late-
phase eosinophilic inflammation.33 In addition, the airways 
become hyperresponsive to nonspecific bronchoconstrictors 
including histamine, methacholine, and adenosine.33,34 CD4+ 
T lymphocytes and natural killer T cells in bronchoalveolar 
lavage fluid are increased, and Th2 lymphocyte cytokines 
are upregulated.35 The severity of the asthma phenotype in 
the NHP model depends on the schedule of allergen chal-
lenges and the provocative dose of HDM. At an exposure 
periodicity of 4–6 week intervals, as used in this study, the 
animals have minimal symptoms between exposures, but 
on the day of provocation, exhibit a severe acute asthmatic 
response, including decrease in arterial O2 saturation to less 
than 80% and in some animals less than 70%. Upon resolu-
tion of the acute response, the animals develop eosinophilia 
that is equivalent to what is observed following segmental 
allergen challenge in asthmatic humans.36 As in humans, the 
symptoms are attenuated with corticosteroids.33,35 Extensive 
terminal protocols have not been conducted on these animals, 
but in a few animals that have been examined, airway wall 
remodeling and mucosal eosinophilia has been observed.33 
These characteristics are consistent with mild to moderate 
intermittent asthma in humans that is well controlled by 
β-agonists and corticosteroids.
The goal of this study was to determine if aerosol allergen 
exposure elicits a delayed, nocturnal response in HDM-
sensitive NHP. Nonallergic and HDM-sensitive animals were 
identified from within an existing colony of Cynomolgus 
macaques. Correlation between RIP measurements and direct 
measures of lung resistance (RL) and dynamic compliance 
(Cdyn) were explored by inducing acute bronchoconstriction 
with aerosolized methacholine and HDM allergen. RIP 
parameters indicative of TAA exhibited a high degree of cor-
relation with the conventional measures of airway function. 
The animals were subsequently challenged with aerosolized 
saline or HDM allergen, and TAA was monitored by RIP for 
20 hours to detect nocturnal disturbances in respiration.
Methods
Overview
Cynomolgus macaques with documented sensitivity to aero-
solized HDM for two or more years prior to the study were 
identified within an existing colony at East Carolina University. 
Animals with no history of allergic sensitivity were used as 
nonallergic controls. Allergy status at the time of the study was 
confirmed by serum levels of HDM-specific IgE, early-phase 
bronchoconstriction to aerosolized HDM, and late-phase eleva-
tion of eosinophils in bronchoalveolar lavage fluid (Table 1).
RIP parameters indicative of TAA were validated by 
simultaneous RIP and conventional determination of RL and 
Cdyn. In an initial session, spontaneously breathing animals 
were challenged with increasing cumulative doses of aero-
solized methacholine to induce graded changes in RL and 
Cdyn. Four weeks later, bronchoconstriction was induced with 
aerosolized HDM allergen, and then reversed by aerosolized 
albuterol. Correlations between RIP parameters, RL, and Cdyn 
were then determined.
Following the validation phase of the study, nocturnal 
responses to daytime allergen challenge were investigated. 
Animals were challenged with aerosolized saline or HDM 
allergen early in the morning. TAA was then monitored by 
RIP throughout the rest of the day and overnight.
Animals
Over a 10-year period prior to the study, 38 Cynomolgus 
macaques were obtained from Alpha Genesis, Inc. 
Table 1 Characteristics of nonallergic and allergic groups
Serum α-HDM-IgE 
(% allergic control)
Eosinophils 
in BAL (%)
Total cells in BAL 
compartment × 106
HDM concentration 
(AU/mL)
ΔRL (%) ΔCdyn (%)
Nonallergic 15.8 ± 3.5 1 ± 0.4 9.58 ± 3.47 2500 ± 0 0.6 ± 5.3 -5.6 ± 4.9
Allergic 70.4 ± 5.1 35.1 ± 4.7 13.65 ± 1.76 360 ± 120.7 103.4 ± 16.7 -47.6 ± 3.4
P value ,0.0001 ,0.0001 0.236 ,0.0001 ,0.0001 ,0.0001
Notes: Values are mean ± Se, nonallergic, n = 11, allergic, n = 21. Animals were exposed to increasing concentrations of hDM in sterile saline until the concentration 
presented in this table elicited the associated ΔRL or ΔCdyn during 15 minutes following the hDM challenge.
Abbreviations: BAL, in bronchoalveolar lavage; hDM, house dust mite; Cdyn, dynamic compliance; RL, lung resistance; Se, standard error of measurement.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
77
Nocturnal thoracoabdominal asynchrony
  (Yemassee, SC) and sensitized to HDM as described 
previously.33,34 Briefly, the animals were sensitized by intra-
peritoneal injections of Dermatophagoides pteronyssinus 
and Dermatophagoides farinae extract adsorbed to Alum 
(156 units of each allergen [Greer Laboratories, Lenoir, NC]; 
Imject Alum [Pierce, Rockford, IL]) at 2–4 week intervals 
for six months. Chronic airway disease was induced by 
subsequent periodic exposure to HDM aerosol at 4–6 week 
intervals. At the time of the study, the animals ranged in age 
from 3.6 to 9.4 years, weighed 2.3 to 7.5 kg, and had exhibited 
allergic asthma symptoms for 1–8 years.
The animals were group-housed in accordance with US 
Department of Agriculture guidelines within a BSL2 facil-
ity at East Carolina University, which is fully accredited 
by the Association for the Assessment and Accreditation 
for   Laboratory Animal Care, International. All protocols 
were approved by the Institutional Animal Care and Use 
  Committee of East Carolina University.
Exposure to allergen between intentional provocations 
was minimized by HEPA (high efficiency particulate air) 
filtration of all air circulating through the animal rooms, 
  rinsing the rooms and cages with pressurized water twice 
each day, and running the cages through an automated washer 
weekly. All personnel entering the rooms wore appropriate 
personal protective gear.
enzyme-linked immunosorbent  
assay for allergen-specific IgE
Serum levels of HDM-specific IgE were measured as described 
previously.33 Ninety-six well plates were coated with HDM 
allergen (10 µg/mL per well, incubated overnight at 4°C in 
0.01 M sodium bicarbonate buffer, pH 9.6). The plates were 
blocked with 10% fetal bovine serum; 100 µL of serum (1:100 
dilutions) was added to the wells. The plates were incubated 
overnight at 4°C. IgE was detected by incubating with 1 µg/mL 
biotinylated goat anti-human IgE (Vector Lab, Burlingame, CA) 
for one hour at room temperature, and then developing with 
streptavidin-conjugated horseradish peroxidase (BD PharMin-
gen, San Diego, CA) and 3,3’,5,5’-tetramethylbenzidine (BD 
PharMingen). The reaction was stopped by addition of sulfuric 
acid, and the absorbance at 450 nm was determined. Relative 
IgE titers were determined by comparison with a serum sample 
pooled from a group of highly allergic animals.
Determination of lung resistance  
and dynamic compliance
Animals were anesthetized with Telazol® 2.0 mg/kg, intra-
muscularly, stabilized on propofol (10 to 15 mg/kg/hour, 
intravenously), and intubated. RL, Cdyn and respiratory 
rate (RR) were measured by a conventional pressure-flow 
technique.33,34 Tracheal airflow was measured using a heated 
Fleisch Pneumotachograph (size 00, Fleisch, Lausanne) con-
nected to a Validyne pressure transducer (Model DP 45-14, 
Validyne Engineering, Northridge, CA). Intrathoracic pres-
sure was measured using an esophageal balloon connected to 
a Model DP 45-24 Validyne pressure transducer. Flow and 
pressure signals were analyzed using a MuMed PR800 lung 
function recorder (MuMed, London). Baselines of RL, Cdyn, 
and RR were determined during a one-minute period of 
quiet breathing. Subsequent responses to aerosolized saline 
(vehicle), methacholine, HDM, and albuterol were expressed 
as raw data or as a percentage change from baseline or saline 
as appropriate.
house dust mite challenge
Baseline pulmonary function was recorded. The animals 
were challenged for four minutes with nebulized sterile 
saline delivered through the endotracheal tube   (Devilbiss 
Ultrasonic Nebulizer, SUN-99HD, Red Lion, PA or 
Nouvag Ultrasonic 2000, Nouvag). Condensation on the 
inner surface of the endotracheal tube was cleared by 
aspiration, and pulmonary function was monitored for 
one minute. The challenge was repeated with increasing 
concentrations of nebulized HDM allergen (1, 10, 100, 
500, 2500 AU/mL) until a 100% increase in RL or a 50% 
decrease in Cdyn was observed.33 Once the target change in 
RL or Cdyn was observed, pulmonary function was monitored 
at five-minute intervals for 15 minutes. Following the last 
recording, the animals were treated with nebulized albuterol 
sulfate (four minutes, 0.083% solution, Ventolin Nebules, 
Orlando, FL).
Arterial oxygen saturation was monitored by pulse 
  oximetry (SurgiVet Model V3304, Harvard Apparatus, 
  Holliston, MA or Cardell® Model 9403 and 9405, Sharn 
  Veterinary Inc., Tampa, FL), and supplemental O2 was deliv-
ered as needed to maintain O2 saturation above 70%.
Methacholine challenge
Animals were anesthetized and instrumented as described 
earlier. Baseline pulmonary function was recorded, and 
sterile saline was delivered for two minutes. Condensa-
tion on the tube was cleared by aspiration, and pulmonary 
function was monitored for one minute. Cumulative doses 
of methacholine (A2251, Sigma, St Louis, MO) between 
0.001 mg/mL and 10 mg/mL were delivered until a 100% 
increase in RL and/or a 50% decrease in Cdyn was observed.33 Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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The range of aerosolized methacholine doses was based on 
previous experience with this model,33 published results 
from tissue bath experiments,37,38 and empiric observations 
with this cohort of animals. A methacholine concentra-
tion of 0.001 mg/mL did not induce bronchoconstriction, 
whereas concentrations greater than 10 mg/mL induced high 
levels of secretions in the airways. Therefore, 10 mg/mL 
methacholine was chosen as the upper level. The provoca-
tive concentration of methacholine leading to a 50% maxi-
mal response (PC50) for RL, Cdyn, and RR was calculated for 
individual animals, and then mean PC50 was determined 
for all animals.
endotracheal bronchoalveolar lavage
Twenty-four hours after HDM challenge, the animals were 
anesthetized with Telazol and propofol, then intubated. 
A sterile 2.5 mm OD Tygon tube was wiped with Surgilube®, 
advanced through the endotracheal tube, and gently wedged 
into an airway. The lung segment beyond the tip of the cath-
eter was lavaged with 7 mL of sterile saline, which was col-
lected by gentle aspiration. Total cell counts were determined 
using a Coulter Counter (Beckman Coulter Instruments, 
Miami, FL). Slides were generated using a Cytospin and 
stained with DiffQuik (VWR Scientific, So. Plainfield, NJ). 
Manual differential cell counts were acquired by counting 
200 cells per sample.
Respiratory inductive plethysmography
RIP parameters were measured using the LifeShirt System 
(Vivometrics, Inc., Ventura, CA). The LifeShirt incorporated 
two parallel sinusoidal wire arrays encircling the thorax and 
abdomen. A small alternating current was passed through the 
wires, inducing a magnetic field. Changes in the shape of the 
arrays during breathing altered the magnetic field, inducing 
a current that was detected as a change in the frequency 
of the applied current, which translated into lung volumes 
and flows on a breath-by-breath basis through coefficients 
obtained during calibration procedures. Changes in animal 
posture and activity were monitored by accelerometers in 
the jackets allowing movement artifacts to be filtered out of 
the dataset.39–41
Animals were fitted with the LifeShirt jackets such 
that the rib cage band was positioned over the sternum 
and the abdominal band positioned immediately cephalad 
to the pelvic girdle.41 The circumference of each band was 
adjusted to provide rib cage and abdomen deflections of 
20 to 200 assumed milliliters (AmL) prior to calibration. 
The LifeShirt jackets were fitted on the animals before 
any   airway challenges began and were left on for about 
24 hours. Raw data records were analyzed with VivoLogic 
software   (Vivometrics, Inc.). The default settings were 
overridden to permit analysis of the small tidal volumes 
(100% tidal  volume = 40 AmL; minimum acceptable tidal 
volume = 2.5%; minimum acceptable effort volume = 2.5%). 
A fixed volume calibration was then performed using the tidal 
volumes recorded by the MuMed lung function recorder dur-
ing the one-minute baseline period.42,43 The calibrated records 
were used to determine the RIP parameters (expressed as 
calibrated raw data or as a percentage change from baseline, 
see below) to be compared with simultaneously determined 
conventional measures of RL and Cdyn.
Three RIP-derived parameters analyzed by the LifeShirt 
software were used as indicators of TAA, ie, phase angle 
(PhAng) of the abdomen and rib cage waveforms, baseline 
effort phase relation (eBPRL), and effort phase relation 
(ePhRL). PhAng is a common parameter used to com-
pare the initial slopes of two sinusoidal waveforms.44 As 
abdominal and thoracic movement become asynchronous, 
PhAng increases. Effort parameters provide an indication 
of the amount of time during a breath that deflection of the 
abdomen and chest wall are asynchronous (ie, the two are 
moving in opposite directions instead of in unison). eBPRL 
is the percentage of time during inspiration that the rib cage 
is moving in the opposite direction from the abdomen, and 
ePhRL is the percentage of time during the total breath that 
the rib cage and abdomen are moving in opposite directions. 
Thus, TAA is associated with increases in PhAng, eBPRL, 
and ePhRL.
Nocturnal study
Following HDM provocation, the animals were recovered 
from anesthesia and returned to their cages. RIP readouts 
were monitored continuously until the next morning. The 
lower threshold for movement artifact was set as the maxi-
mum acceleration values associated with quiet breathing for 
each animal while under anesthesia. All records associated 
with accelerations greater than this maximum value were 
removed from the dataset.
Thirty-minute averages of eBPRL and ePhRL (but not 
PhAng, see Results section) were plotted from 1 pm the day 
of HDM provocation until 6 am the next day. A 30-minute 
period between 1 pm and 10 pm was identified during which 
there was little animal movement and low incidence of TAA 
(ie, minimum average eBPRL or ePhRL for the period, 
labeled as baseline in Figure 4). This relatively normal, 
quiet breathing period served as a baseline for the nocturnal Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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studies. eBPRL and ePhRL were plotted against time and 
the area under the curve (AUC) between 10 pm the day 
of HDM   challenge and 5 am the next day was determined 
using SigmaPlot Version 10 (Systat Software, Inc., San Jose, 
CA, see Figure 4). The AUC was used as an indicator of 
TAA incidence and to compare nocturnal responses among 
subjects.
Statistics
Recorded respiratory parameters were expressed as calibrated 
raw data or as a percentage change from the baseline control 
period. The relationships between RL, Cdyn, RR, and RIP 
parameters were investigated by simple and multiple linear 
regressions using SPSS software (SPSS, Inc., Chicago, IL). 
The methacholine PC50 of each parameter was determined by 
Hill fit analysis for each animal (Systat Software, Inc., San 
Jose, CA). Differences between two means were assessed 
by Student’s t-test for independent observations (P # 0.05). 
Differences between three or more means were assessed by 
one-way analysis of variance (ANOVA) with Tukey HSD 
post hoc test (P # 0.05). Values are reported as mean ± 
standard error of measurement.
Results
Methacholine and hDM challenges
To validate RIP as a measure of TAA associated with under-
lying airway responses, the relationships between RL, Cdyn, 
and RIP parameters indicative of TAA were defined under 
controlled conditions where methacholine and HDM were 
used to induce acute bronchoconstriction, and albuterol to 
induce bronchodilation.
Nonallergic animals had minimal changes in all param-
eters at the highest concentration of methacholine (data not 
shown), whereas in allergic animals the highest concentration 
of methacholine increased RR and RL and decreased Cdyn. 
RR exhibited a higher sensitivity to methacholine than Cdyn 
and RL, while Cdyn exhibited sensitivity to methacholine that 
was intermediate between RR and RL (Table 2). These results 
were consistent with independent modulation of RR and RL, 
and with changes in Cdyn that were due to reduced alveolar fill-
ing time as RR increased. Multiple linear regression of values 
recorded before and after methacholine challenge revealed 
significant associations of RL and Cdyn with eBPRL, ePhRL 
and PhAng (eBPRL: r = 0.49, P , 0.05; ePhRL: r = 0.41, 
P , 0.05; PhAng: r = 0.45, P , 0.05).
At a later date, the animals were challenged with aero-
solized HDM antigen to induce acute bronchoconstric-
tion, and were then treated with albuterol to reverse the 
HDM-induced bronchoconstriction. When the effects of 
HDM and albuterol were separated, the RIP parameters 
tracked closely with changes in Cdyn and RL (Figure 1). 
Although the   directions of Cdyn and RL were opposite, the 
relative magnitude of HDM-induced changes were similar 
(ΔCdyn: P = 0.0001 and ΔRL: P = 0.001, HDM versus saline) 
and both parameters exhibited at least partial reversal with 
albuterol (Figures 1B and 1C). HDM provoked increases 
in eBPRL, ePhRL, and PhAng (P , 0.01, HDM versus 
saline) that were reversed by albuterol (Figures 1D–1F). In 
contrast, RR increased with HDM (P , 0.001, HDM versus 
saline), but did not reverse with albuterol (Figure 1A). These 
results demonstrated that TAA, as measured by changes 
in RIP, coincided with changes in RL and Cdyn induced by 
diverse agents.
The aggregate HDM and albuterol data were analyzed 
by multiple linear regression, which revealed associations of 
RL and Cdyn with eBPRL, ePhRL, and PhAng as described 
by the following equations (See Table 3):
eBPRL = 26.8 – 3.8 Cdyn + 1.7 RL
ePhRL = 30.2 – 4.4 Cdyn + 1.7 RL
PhAng = 98.6 – 11.4 Cdyn + 2.1 RL
Thus, the RIP parameters increased as Cdyn decreased and, 
independently, after adjustment for Cdyn, the RIP parameters 
increased as RL increased. The regression equations were 
consistent with an inverse relation between RL and Cdyn. This 
relationship was verified by plotting coincident values of RL 
against Cdyn for data collected during both the methacholine 
and HDM challenges. The resulting curve exhibited an 
inverse first-order relationship (r = 0.69, P , 0.05 by simple 
linear regression of 1/RL versus Cdyn).
Nocturnal asthmatic response  
to house dust mite challenge
In follow-up experiments to those discussed above, animals 
were challenged with aerosol HDM between 6 am and 
10 am, and then acute bronchoconstriction was reversed 
with albuterol. The animals were recovered from anesthe-
sia, and returned to their cages. Excursions of the rib cage 
Table 2 Methacholine PC50 of conventional respiratory indexes
Methacholine  
PC50 (mg/mL)
P value
Mean SE RR Cdyn RL
RR 0.07 0.01 – 0.031 0.001
Cdyn 0.23 0.05 0.031 – 0.001
RL 0.63 0.09 0.001 0.001 –
Abbreviations: RR, respiratory rate; Cdyn, dynamic compliance; RL, lung resistance; 
Se, standard error of measurement.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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and the abdomen were monitored continuously until the 
next   morning. Figure 2 shows representative RIP record-
ings for one animal while anesthetized during the baseline 
and the early asthmatic response (Figure 2, left panels), 
and later while conscious during the afternoon or evening 
baseline and the nocturnal asthmatic response (Figure 2, 
right panels). PhAng (calculated from the Konno-Mead 
diagram) has been used in previous studies to assess 
TAA.15,41,44 However, PhAng is affected by the shape of the 
abdominal and ribcage waveforms, as in Tables and other 
figures with a triangular waveform being associated with 
increased error.15,41 Triangular waveforms were commonly 
observed in the current study (Figure 2) and, therefore, 
PhAng was not used as an indicator of TAA at night. The 
effort parameters, eBPRL and ePhRL, correlated well with 
labored breathing exhibited during the acute response to 
HDM and methacholine provocation, and were therefore 
used to monitor for nocturnal respiratory disturbances.
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To assess the long-term stability of eBPRL and ePhRL, 
both parameters were recorded in nonallergic animals over-
night. No significant change was observed in eBPRL and 
ePhRL over the nocturnal time period between 10 pm and 
5 am (Figure 3), whereas in most allergic animals, eBPRL 
and ePhRL gradually increased from the baseline, reach-
ing a peak value around 3:30 am (Figure 4). To quantify 
nocturnal TAA, we determined the AUC between 10 pm 
and 5 am and determined the 99% confidence intervals 
for nonallergic animals (dashed line in Figure 5A and B). 
Plots of eBPRL and ePhRL against time for allergic animals 
revealed 15 of 21 animals with AUCs greater than the upper 
boundary of the 99% confidence interval. These 15 animals 
were therefore classified as nocturnal asthmatic respond-
ers (NARs). The allergic group mean AUCs for changes 
in eBPRL and ePhRL were greater than the nonallergic 
control group mean AUCs (Figure 5A and B, ΔeBPRL: 
P , 0.001, ΔePhRL: P = 0.001). In control experiments, the 
NAR group did not exhibit   nocturnal responses following 
challenges between 6 am and 10 am with aerosolized saline 
alone (data not shown).
To evaluate the reproducibility of the nocturnal 
response, eight animals exhibiting acute responses to 
HDM were rechallenged at a later date (Figure 6). Six of 
the animals had been classified as NARs in the previous 
trial (shown as six symbols above the dashed lines for 
challenge number 1, Figure 6) and two animals had not 
been classified as NARs. Four of these six NARs from 
the first trial exhibited nocturnal responses following the 
second challenge (Figure 6). Both the animals that had 
not been classified as NARs in the previous trial exhibited 
nocturnal responses for the second challenge. Conversely, 
two animals that exhi  bited a nocturnal response following 
the first challenge exhibited minimal increase in eBPRL 
and ePhRL following the second challenge.   Manifestation 
of a nocturnal response and its magnitude could not be 
attributed to the provocative concentration of HDM used 
to elicit the early-phase response or the magnitude of the 
change in RL and Cdyn during the early-phase response (data 
not shown).
Discussion
In spontaneously breathing animals, large and small airway 
constriction manifest as changes in resistance and compli-
ance. These changes may contribute to TAA which results 
from inability of thoracic volume to change in phase with 
abdominal volume due to restricted airflow through the 
lungs. To our knowledge, this is the first report on the 
use of RIP to measure TAA in a NHP model of allergic 
asthma and to apply the technique to document nocturnal 
responses in animals following allergen challenge. TAA as 
indicated by RIP eBPRL and ePhRL parameters correlated 
with changes in Cdyn and RL in Cynomolgus macaques 
during bronchoconstriction induced by methacholine or 
HDM, and bronchodilation induced by albuterol. Follow-
ing HDM challenge in the early morning, TAA was shown 
to increase, with a peak between 3 am and 4 am the next 
morning. The nocturnal response exhibited intra-animal 
variability in both incidence and magnitude, which is 
consistent with manifestation of nocturnal asthma symp-
toms in humans.
RIP has been used extensively to assess apnea and 
breathing patterns during sleep in humans20,21,23,24,26 
and animals.45 Multiple human studies have demon-
strated correlations among TAA, bronchoconstriction, 
and bronchodilation.15,25,44 In contrast with TAA, other 
RIP parameters, particularly ventilation, do not appear to 
be useful in assessing pulmonary function in asthmatic 
subjects,19,46 possibly due to artifact induced in volume 
measurements by asynchronous movement of the chest 
wall and abdomen during   bronchoconstriction.47 In this 
study of allergic NHP, TAA as measured by RIP correlated 
with changes in RL and Cdyn during HDM- and methacho-
line-induced bronchoconstriction. In contrast, a previous 
study in foals did not observe these correlations during 
histamine-induced bronchoconstriction.12 The reason for 
this discrepancy is not clear.
In asthmatics there is a high prevalence of nocturnal 
symptoms,2,3 with peak pulmonary resistance3 and airway 
Table  3  Multiple  linear  regression  results  of  eBPRL,  ePhRL, 
and PhAng recorded during the first 30 minutes following HDM 
challenge
Dependent 
variable
Independent 
variable
Regression 
coefficients
tbj P
Bj SE sbj
eBPRL Intercept
Cdyn
RL
26.80
-3.85
1.65
13.72
1.25
0.41
1.95
-3.08
4.08
0.056
0.003
,0.001
ePhRL Intercept
Cdyn
RL
30.15
-4.43
1.68
13.99
1.27
0.41
2.16
-3.48
4.06
0.035
0.001
,0.001
PhAng Intercept
Cdyn
RL
98.62
-11.42
2.07
25.20
2.29
0.74
3.91
-4.98
2.782
,0.001
,0.001
0.007
Note: The P value is a test of h0: βj = 0 against ha: βj ≠ 0.
Abbreviations:  hDM,  house  dust  mite;  RR,  respiratory  rate;  Cdyn,  dynamic 
compliance; RL, lung resistance; eBPRL, baseline effort phase relation; ePhRL, effort 
phase relation; PhAng, phase angle; Se, standard error or measurement.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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inflammation4,5 observed around 4 am. In this study of 
allergic NHP, both eBPRL and ePhRL gradually increase 
during the night following an early morning HDM 
  challenge, which is consistent with the time course of 
nocturnal symptoms in humans. These nocturnal increases 
in TAA may be linked to underlying bronchoconstriction, 
but this cannot be proven without overt intervention at 
night. TAA is also impacted by changes in respiratory 
muscle load, control of auxiliary muscles of breathing, 
and respiratory muscle dysfunction.22 These factors can-
not be excluded as underlying causes of nocturnal TAA. 
Regardless, the data provide   compelling   evidence that 
daytime exposure to allergen results in   nocturnal distur-
bances in breathing.
The incidence and severity of nocturnal asthma symp-
toms in humans is variable, both between and within 
subjects.7,48 Likewise, nocturnal TAA following HDM 
challenge in allergic NHP was variable between animals 
and within individual animals over time. Shigemitsu 
et al49 reported that 60% of asthmatic subjects manifest 
nocturnal   symptoms. This   number compares favorably 
with the 71% incidence observed in the current study. Fix 
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Figure 2 Representative RIP recordings of one animal (ID: 8065) during both the early asthmatic response and the nocturnal asthmatic response. Excursions of the rib cage (RC) and 
the abdomen (AB), as well as corresponding eBPRL, ePhRL, and PhAng are shown for multiple breaths. Note the triangular RC and AB wave forms, and that eBPRL and ePhRL are 
better reflections of TAA than PhAng during the early asthmatic response peak and also are good reflections of TAA during the nocturnal asthmatic response peak. The Konno-Mead 
diagram (bottom of each vertical panel) shows the direction of RC movement (dRC) and the direction of AB movement (dAB) during inhalation and exhalation in three breaths.
Abbreviations: AB, abdomen; RC, rib cage; eBPRL, baseline effort phase relation; ePhRL, effort phase relation; PhAng, phase angle; TAA, thoracoabdominal asynchrony.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
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Figure 4 Representative nocturnal eBPRL and ePhRL response of the same animal represented in Figure 2 (ID: 8065). Plot of eBPRL (filled circle) and ePhRL (open circle) 
(30-minute averages) starting at 1 pm and ending at 6 am next morning. AUC was started at 10 pm and ended at 5 am.
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Figure 6 Reproducibility of the nocturnal response to hDM challenge. eight animals were challenged with hDM on two different dates. AUC for (A) eBPRL and (B) ePhRL 
are shown. Symbols represent individual animals. Dash lines represent the upper limit of the 99% confidence intervals for the nonallergic group. The symbols above the dashed 
lines were classified as nocturnal asthmatic responses.
Abbreviations: eBPRL, baseline effort phase relation; ePhRL, effort phase relation; AUC, area under the curve; hDM, house dust mite.
et al reported that occurrence of nocturnal symptoms is 
linked to the   severity of asthma,50 but other investigators 
fail to substantiate a definitive link between any particu-
lar phenotypic feature of early acute allergic responses 
and late asthmatic responses in humans and animals,51–53 
including the occurrence of nocturnal symptoms.7 In 
the NHP model, nocturnal TAA could not be attributed 
to any of the functional parameters measured during 
the early asthmatic response, including the provocative 
concentration of HDM or the magnitude of the acute 
bronchoconstriction.
Conclusion
In summary, RIP parameters indicative of TAA correlated 
with decrease in pulmonary function during methacholine 
challenge and the early asthmatic response in HDM-sensitive 
Cynomolgus macaques. Using RIP as a measure of TAA 
revealed nocturnal changes in pulmonary function follow-
ing daytime exposure to aeroallergen. While increased TAA 
is consistent with bronchoconstriction, the changes may 
not be due solely to changes in RL and Cdyn. Regardless, the 
results provide compelling evidence that daytime exposure to 
aeroallergen in allergic NHP is associated with an increased 
incidence of nocturnal disturbances in breathing. Taken 
together, the results indicate that symptoms of nocturnal 
asthma can be induced in NHP, providing a model for eluci-
dating the mechanisms underlying circadian manifestation 
of asthma symptoms.Journal of Asthma and Allergy 2010:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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